🕒 Wednesday 4 June 2025 Wed, 4 June 2025

Nyrada has secured ethics approval to amend its Phase I clinical trial protocol for Xolatryp, allowing testing of higher doses and extended infusion times. This strategic move aims to refine dosing ahead of Phase II trials, with final Phase I results expected by September 2025.

Elph Investments has raised and finalised its off-market takeover bid for Engenco Limited shares at $0.31 per share, applying to all shareholders including those who already accepted. This move signals a decisive step in the ongoing acquisition process.

Keybridge Capital has lodged a formal complaint with the Takeovers Panel, alleging improper dilution of its voting power in Yowie Group via the HHY Fund ahead of a pivotal shareholder meeting.

QuickFee Limited reports mixed Q4 FY25 results with solid growth in US Pay Now and Australian Finance, offset by a significant US Finance decline due to credit impairment. The company completes a major refinancing and capital raise while maintaining FY25 earnings guidance.

QuickFee Limited has launched a A$1.5 million capital raising to fund expansion of its loan books in the US and Australia, following a quarter of record revenue and positive earnings before tax. The fintech also completed a major refinancing and revised its earnings guidance due to a credit impairment provision.

QuickFee Limited has completed a significant A$118 million debt refinancing and successfully raised A$1.25 million through a share placement, alongside announcing a new Share Purchase Plan to support its expansion in the US and Australian markets.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.

Anax Metals has issued a detailed clarification on its recent $3.3 million convertible note placement with Mineral Development Partners, addressing inconsistencies in shareholder approval disclosures and announcing strengthened compliance measures.

Vertex Minerals confirms fully developed, accessible stope blocks at its Reward Mine, featuring a high-grade inferred resource that promises to accelerate underground production start-up.

ClearVue Technologies’ subsidiary OptiCrop has secured its inaugural commercial project, an $80,000 greenhouse installation leveraging proprietary ground-source heat exchange technology. This milestone underscores ClearVue’s strategic expansion into sustainable protected cropping and greenhouse agriculture.

National Storage REIT has partnered with GIC to invest $228 million in a second tranche of self-storage development assets, reaffirming its FY25 earnings guidance and strategic growth plans.

Chimeric Therapeutics has secured FDA Fast Track designation for its CHM CDH17 CAR-T therapy targeting gastroenteropancreatic neuroendocrine tumours, accelerating its path toward regulatory approval and patient access.

Ovanti Limited is set to raise approximately $1 million through a two-tranche share placement to support its US buy now, pay later expansion and ongoing legal matters.

Andromeda Metals has achieved a key financing milestone with Merricks Capital's credit approval of a A$75 million debt facility, advancing the Great White Project towards final investment decision.

Patriot Resources has identified a significant new copper mineralisation zone within its Sugarloaf licence in Zambia, revealing promising surface copper grades and a substantial strike length that could expand its resource base.

Tivan Limited has fully redeemed its convertible notes issued to SBC Global Investment Fund ahead of schedule, marking a significant step in its financial restructuring. The company now plans to remove SBC’s security interests on its assets before the fiscal year ends.

Dominion Income Trust 1 (ASX – DN1) has announced a wholesale placement of 450,000 new units, aiming to raise $45.45 million at $101 each. The placement targets wholesale investors and supports monthly distributions with a competitive target return.

Dominion Income Trust 1 (ASX – DN1) has announced a $45 million placement at $101 per unit, aiming to enhance fund diversification and liquidity without impacting net asset value.

Challenger Gold Limited has voluntarily suspended its ASX trading pending a significant capital raising announcement, signaling potential strategic moves ahead.

Elsight has landed a significant US$5.08 million contract with a European defence OEM, pushing its total 2025 orders from this customer to nearly US$14.7 million and signaling strong growth in unmanned systems connectivity.

CZR Resources has secured Foreign Investment Review Board approval for the sale of its Robe Mesa Iron Ore Project, marking a significant step toward closing the A$75 million transaction.

New Frontier Minerals Ltd highlights significant exploration progress at its Harts Range heavy rare earths project and the NWQ Copper Project, backed by strategic partnerships and promising assay results.

New Frontier Minerals has secured $1.59 million in funding to launch its inaugural drilling campaign targeting heavy rare earth elements, niobium, and uranium at the Harts Range Project, aligning with favorable US policies on supply chain diversification and nuclear energy.

Adelong Gold Limited has secured $455,000 from selling a non-core property to fund exploration at its Victorian gold projects, while gold processing has commenced at its Challenger Gold Mine, signaling imminent production.